Holen Sie sich die Stockscreener-App
26.13
2.63%
0.67
Finanzdaten der Stoke Therapeutics Inc-Aktie (STOK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
49.70%
9.325
|
6.229 | 1.402 | 10.63 | 13.82 |
Operating Expenses
|
25.33%
74.75
|
59.65 | 62.84 | 53.72 | 41.12 |
| Interest Income/Expense |
26.09%
0.017
|
0.023 | 0.003 | 0.003 | 0.003 |
| Operating Income/Loss |
22.48%
-65.43
|
-53.42 | -61.44 | -43.09 | -27.30 |
| Nonoperating Income/Loss |
11.60%
3.811
|
3.415 | 3.505 | 3.466 | 3.817 |
| Income/Loss From Continuing Operations Before Tax |
23.23%
-61.62
|
-50.00 | - | -39.62 | -23.48 |
| Income Tax Expense/Benefit |
-
|
- | - | -1.278 | - |
| Net Income/Loss |
23.23%
-61.62
|
-50.00 | -57.93 | -38.35 | -23.48 |
| Basic Average Shares |
4.68%
66.02
|
63.06 | - | 58.61 | 58.35 |
| Diluted Average Shares |
4.68%
66.02
|
63.06 | - | 58.61 | 58.35 |
| Basic Earnings Per Share |
17.72%
-0.93
|
-0.79 | - | -0.65 | -0.40 |
| Diluted Earnings Per Share |
17.72%
-0.93
|
-0.79 | - | -0.65 | -0.40 |
12.15%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):